WVE - Wave Life Sciences Ltd. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - WVE (1631574)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
22 results - Yahoo - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2020-07-02
WVEBolno PaulPres, CEOS - Sale+OE$10.30-147,577272,181-35%-$1,520,276
2020-02-18
WVEPanzara Michael A.Chief Medical OfficerS - Sale$7.85-2,98139,349-7%-$23,401
2020-02-18
WVEBolno PaulPres, CEOS - Sale$7.85-11,451319,758-3%-$89,890
2020-02-18
WVEFrancis ChrisSee RemarksS - Sale$7.85-2,70831,160-8%-$21,258
2020-02-18
WVEVargeese ChandraSVP, Drug DiscoveryS - Sale$7.85-3,18837,057-8%-$25,026
2020-02-03
WVEGaiero David GInterim CFOS - Sale$7.00-6516,392-9%-$4,557
D
2019-12-03
WVEVargeese ChandraSVP, Drug DiscoveryS - Sale+OE$35.00-6,00040,245-13%-$210,000
2019-11-20
WVEVerdine Gregory L.DirS - Sale$30.63-30,03930,000-50%-$920,213
2019-07-05
WVEPanzara Michael A.Chief Medical OfficerS - Sale$26.94-3,05842,330-7%-$82,368
D
2019-03-15
WVEBolno PaulPres, CEOS - Sale+OE$45.48-50,000331,209-13%-$2,273,804
2019-03-11
WVEPanzara Michael A.Franchise Lead, NeurologyS - Sale$48.00-7,00045,388-13%-$336,000
2019-02-19
WVERegnante KeithCFOS - Sale$36.84-1,29815,686-8%-$47,818
2019-02-19
WVEPanzara Michael A.Franchise Lead, NeurologyS - Sale$36.84-1,83737,388-5%-$67,674
2019-02-19
WVEBolno PaulPres, CEOS - Sale$36.40-7,733271,209-3%-$281,456
2019-02-19
WVEVargeese ChandraSVP, Drug DiscoveryS - Sale$36.84-2,05525,245-8%-$75,706
2019-02-19
WVEFrancis ChrisSee RemarksS - Sale$36.84-1,70920,368-8%-$62,959
2019-01-24
WVERa Capital Management, LLCDir, 10%P - Purchase$38.00+263,1587,775,207+4%+$10,000,004
2018-11-14
WVEVerdine Gregory L.DirS - Sale$38.86-15,00060,039-20%-$582,849
DM
2018-09-24
WVEFrancis ChrisSee RemarksS - Sale+OE$56.00-11,57522,077-34%-$648,200
D
2018-09-24
WVERegnante KeithCFOS - Sale+OE$55.00-29,50016,984-63%-$1,622,500
D
2018-09-24
WVEVargeese ChandraSVP, Drug DiscoveryS - Sale+OE$55.00-3,00027,300-10%-$165,000
D
2018-07-09
WVEFrancis ChrisSee RemarksS - Sale+OE$37.27-24,49622,077-53%-$913,054
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top